Spire Wealth Management
RVMD icon

Spire Wealth Management’s Revolution Medicines RVMD Stock Holding History

Spire Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.45M Buy
16,790
+650
+4% +$129K 0.11% 182
2026
Q2 		$3.02M Buy
+16,140
New +$2.36M 0.09% 198
2025
Q4 		– Sell
-105
Closed -$4.9K – 2453
2025
Q3 		$4.9K Hold
105
– – ﹤0.01% 1960
2025
Q2 		$3.86K Sell
105
-13
-11% -$499 ﹤0.01% 2023
2025
Q1 		$4.17K Hold
118
– – ﹤0.01% 2106
2024
Q4 		$5.16K Buy
118
+105
+808% +$5.3K ﹤0.01% 2036
2024
Q3 		$590 Hold
13
– – ﹤0.01% 2138
2024
Q2 		$505 Buy
+13
New +$486 ﹤0.01% 2195

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Spire Wealth Management's RVMD Position: Q3 2026 in Review

Spire Wealth Management increased its Revolution Medicines (RVMD) stake by 4% in Q3 2026, buying an estimated $129K and bringing the position to 16,790 shares worth $3.45M. The position accounts for 0.11% of the portfolio, ranked #182.

Spire Wealth Management first reported a position in RVMD in Q2 2024 and has held it in 8 quarters since. 490 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Spire Wealth Management held 16,790 shares of Revolution Medicines worth $3.45M as of Q3 2026.
  • Spire Wealth Management bought 650 Revolution Medicines shares in Q3 2026, an estimated $129K.
  • Revolution Medicines made up 0.11% of Spire Wealth Management's portfolio in Q3 2026, its #182 holding.
  • Spire Wealth Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 8 quarters since.
  • 490 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.